☰

Claude Dagenais, Ph.D. - Publications

Affiliations: 
2001 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacy, Neuroscience Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Dagenais C, Avdeef A, Tsinman O, Dudley A, Beliveau R. P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 38: 121-37. PMID 19591928 DOI: 10.1016/J.Ejps.2009.06.009  0.485
2004 Dagenais C, Graff CL, Pollack GM. Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochemical Pharmacology. 67: 269-76. PMID 14698039 DOI: 10.1016/J.Bcp.2003.08.027  0.572
2002 Demeule M, Régina A, Jodoin J, Laplante A, Dagenais C, Berthelet F, Moghrabi A, Béliveau R. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascular Pharmacology. 38: 339-48. PMID 12529928 DOI: 10.1016/S1537-1891(02)00201-X  0.619
2002 Demeule M, Poirier J, Jodoin J, Bertrand Y, Desrosiers RR, Dagenais C, Nguyen T, Lanthier J, Gabathuler R, Kennard M, Jefferies WA, Karkan D, Tsai S, Fenart L, Cecchelli R, et al. High transcytosis of melanotransferrin (P97) across the blood-brain barrier. Journal of Neurochemistry. 83: 924-33. PMID 12421365 DOI: 10.1046/J.1471-4159.2002.01201.X  0.608
2002 Dagenais C, Ducharme J, Pollack GM. Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: liquid chromatography-mass spectrometry analysis and internal standard strategy. Journal of Pharmaceutical Sciences. 91: 244-52. PMID 11782913 DOI: 10.1002/Jps.1175  0.738
2001 Régina A, Demeule M, Laplante A, Jodoin J, Dagenais C, Berthelet F, Moghrabi A, Béliveau R. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Reviews. 20: 13-25. PMID 11831641 DOI: 10.1023/A:1013104423154  0.45
2001 Dagenais C, Zong J, Ducharme J, Pollack GM. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds. Pharmaceutical Research. 18: 957-63. PMID 11496955 DOI: 10.1023/A:1010984110732  0.688
2001 Cisternino S, Rousselle C, Dagenais C, Scherrmann JM. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice Pharmaceutical Research. 18: 183-190. PMID 11405289 DOI: 10.1023/A:1011080418027  0.704
2001 Dagenais C, Ducharme J, Pollack GM. Uptake and efflux of the peptidic delta-opioid receptor agonist. Neuroscience Letters. 301: 155-8. PMID 11257421 DOI: 10.1016/S0304-3940(01)01640-8  0.749
2000 Dagenais C, Rousselle C, Pollack GM, Scherrmann JM. Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 381-6. PMID 10698076 DOI: 10.1097/00004647-200002000-00020  0.677
Show low-probability matches.